AKT1 and early-onset autosomal dominant Alzheimer disease: Activation of the PI3K/Akt pathway was considered neuroprotective in various models of neuronal toxicity (Huang et al., 2012; Yu et al., 2017), Alzheimer's disease (Ali and Kim, 2015) and cerebral ischemia (Simão et al., 2012).